[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-NAGE":3,"homepage-market-summary":31,"stock-news-NAGE":174},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"NAGE","2026-10-06",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Niagen Bioscience, Inc. Common Stock","Nasdaq",null,"MEDICINAL CHEMICALS & BOTANICAL PRODUCTS","Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.","117","Los Angeles, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},2.69,2.67,2.705,2.66,2.68,0.01,0.37,368313.35228,3783,2.6858,7.95,2.61,887580.2003093625,1.5,4598,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51521,253,0.49,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":14,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",239.24,0.34,0.14,"0.0,14.1 7.3,16.0 14.7,14.6 22.0,11.8 29.3,8.2 36.7,2.4 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.63,0.74,0.22,"0.0,2.0 7.3,16.0 14.7,10.4 22.0,14.6 29.3,9.3 36.7,10.6 44.0,9.4",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",380.68,1.95,0.51,"0.0,13.7 7.3,16.0 14.7,15.0 22.0,15.4 29.3,7.1 36.7,3.0 44.0,2.0",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",0.53,202,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.24,54.01,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.17,167.09,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.2,111.75,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.9,81.77,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.47,63.75,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.87,171.58,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.46,49.73,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",1.06,41.1,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",2.98,41.16,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.04,111.65,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",779.09,0.55,{"ticker":162,"name":163,"price":164,"change":138,"is_up":40},"QQQ","Invesco QQQ Trust",759.69,{"ticker":166,"name":167,"price":168,"change":47,"is_up":40},"DIA","SPDR Dow Jones ETF",514.56,{"ticker":170,"name":171,"price":172,"change":173,"is_up":14},"IWM","iShares Russell 2000",281.37,-0.71,{"ticker":4,"count":175,"articles":176},9,[177,183,189,195,201,206,212,218,224],{"title":178,"link":179,"pubDate":180,"description":181,"source":182},"Niagen Bioscience, Inc. (NAGE) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE8zMHFSWjJKLTYySDViQUlnX1RlejNfaEJVODJldXFNTDE3a2hEanluWXN5b2hHajROc3Z1bEVLOUpCOEdMVnNQdk9TMzc4azV1TlE?oc=5","Tue, 06 Oct 2026 13:55:56 GMT","Niagen Bioscience, Inc. (NAGE) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":184,"link":185,"pubDate":186,"description":187,"source":188},"A healthy-aging research company’s CEO is set to speak in Los Angeles Oct. 21. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxNbGloYTM1WWxSS1Mtc1NOTVNwV1BqaFgyUmgwX0YxdVprZ0YwYy1iSHNrS3VpV0Z1dEE0emVKaHd2QlhEc3RoY0ZxNmd1U3RuaWtZY3FZQ2tOTFNVbUxWZlo0SU4zV0RJS3lMZkw2bnlpMk9nWDUzczFaRzM0SVY0NUJwQkgya1hDZ0Q1WjFhSHRmS0c0eURVQ1hmejZlcnZqb0ZhQVhYenR2c1BOcFRJWmN3?oc=5","Tue, 06 Oct 2026 12:32:00 GMT","A healthy-aging research company’s CEO is set to speak in Los Angeles Oct. 21. Stock Titan","Stock Titan",{"title":190,"link":191,"pubDate":192,"description":193,"source":194},"Niagen Bioscience: Down 68%, But Still Not Quite A Buy (NASDAQ:NAGE) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxNVEVmM0ZXdGk0M0Q1TlJaWk1sRHZvNldfTnZjTGhZdTR4MjlqdzRRNlV3Sy03QURsY2FTQjU1Y0RIVFkyNEY3NEkzbkpvM2xBZDFUOEt0dnhfeERxbllaLXJwb2ZlbFpDM21RblRKUjFqRWRzbUhVaXdjVC15VjNCbVZOWF92QWdGWUNOTm9iMTFjYTdDSXhlZmZDYmM3eEpEQUE?oc=5","Tue, 29 Sep 2026 14:05:08 GMT","Niagen Bioscience: Down 68%, But Still Not Quite A Buy (NASDAQ:NAGE) Seeking Alpha","Seeking Alpha",{"title":196,"link":197,"pubDate":198,"description":199,"source":200},"Transcript: Niagen Bioscience Q2 2026 Earnings Conference Call - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxQZjRSZXF4MkhLR3FiWHVNNl9ZdFhIYlNTWGJqdVhxM0lCcUQ2bnl6dTYxOXlkRjBad3NyNzlCN1lHdG93dnFYSFVrMmdUdUswdXJ2b0Y4SDZHUDhSWlNlNWlkakJrdUdmczdudDBPZUdKdVJmbnhoeF93YlhQdkppVDQtS1g4YXZyVVNqNW55UVk4UnRKSnczcTJIWV9IMlljMFhBMTB0MkVmZw?oc=5","Wed, 30 Sep 2026 10:55:42 GMT","Transcript: Niagen Bioscience Q2 2026 Earnings Conference Call Benzinga","Benzinga",{"title":202,"link":203,"pubDate":204,"description":205,"source":188},"At 54, 11-time surfing champion Kelly Slater still competes—and fronts Niagen's new campaign. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxPdUJ0VmpiMzdMdFcyakJUM1gxd2ZWU3FuNVZpaHNxeC0zRDJHNUIwTW4wQnpwRktjVWpyTzQ4TGdUYWV1SE8wcWVCS0cxOE9LbGRUMk1yenJkdHRYbHc0S1BqNGtKZ0dGZktHVlBxalo2ZEloTlVIWEdCN3JYMWg1RVh5VE0wUFMxUnhZYTNHTjhOYXoyN0dHc29zVFBhOF9FdWR4QnR6TjM2YWtjRXhnNEtNWnFoRG5NQVZnOXpMcw?oc=5","Thu, 01 Oct 2026 12:32:00 GMT","At 54, 11-time surfing champion Kelly Slater still competes—and fronts Niagen's new campaign. Stock Titan",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Canaccord reiterates Niagen stock rating on healthy aging strategy - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxPN3dtQ3YzMkZ2djdWU09YejNCNVV4QWFHakRmNDFtZHU4MGNCTU1XVFpVRWltZGN1S0ZzTVdlZTNfWHBhbUlyU0swZTRiVEtJMkdyMHNLWU1oOE9kV01abmdIR29XdTBVR2MydFZEdnktMUUwWTA1RzFLQTF0YnNUYzhUNFk5ekRybnI0dmlhQUZRNUNEcXBISzdPSENvYi1vd1pKYnZLMTN3ZlhPWk5Ia1I5cFZjNzJRV3I5WW94ODUzbnBV?oc=5","Mon, 05 Oct 2026 12:24:34 GMT","Canaccord reiterates Niagen stock rating on healthy aging strategy Investing.com","Investing.com",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"Niagen Bioscience, Inc. Begins Detailed Planning with Mass General Brigham for Healthy Aging Clinical Trial Evaluating Niagen Supplementation - www.marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxOMXlpZE8xdGZIZEg4dGNxM2ozY3huU1o4LXBHVTU1cVkzd1Y0OW41c0RlQ1ZlTE9UWHA0dWZPTThNTVJiM09mQ0NzWVluTlBlMUdGdHZZRWdEWmVsY0tpaGJ6NkJHRkt0ZlhHTGpLNGFTN0dHLWJwNy1nLWp3QjBmSnNMVUtmMEtJNHNZNEtoUnFvdVBDYndJV3Q0UnlLdFVWanZBclNhX2ljclhWOVdmQy1HM19RWlNNTFFSUWdxX2UzWFY4NWhSYzFfemFHQzJUZ1QyU0JCazFrZFZnWGlOS3dfeWpqdw?oc=5","Wed, 30 Sep 2026 18:37:05 GMT","Niagen Bioscience, Inc. Begins Detailed Planning with Mass General Brigham for Healthy Aging Clinical Trial Evaluating Niagen Supplementation www.marketscreener.com","www.marketscreener.com",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"Niagen Bioscience (NAGE): Can Its NAD+ Business Drive the Next Leg of Growth? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxNR0kwb2h5U0IzR210aUNrMk9QQzdrZm84cFFyVFhUakZoWm9UN2ZNcmRNcm1hNFN0SU01cFoxVjM5eG8wc3RGaHh1VjFKeU1lWlAxaU1WU1ROU2huSHJ6NGEzN1M5Vmkxb2FiTEY1aWpxMmUxWVRvaE8tS1U3T3lQbHlONkEwR2pwSWRST0RyaEdjczZZbE1VM0U1aFI?oc=5","Wed, 30 Sep 2026 16:59:53 GMT","Niagen Bioscience (NAGE): Can Its NAD+ Business Drive the Next Leg of Growth? Yahoo Finance","Yahoo Finance",{"title":225,"link":226,"pubDate":227,"description":228,"source":229},"Niagen Bioscience signs agreement for clinical trial planning By Investing.com - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxOc0FZY1VlZG9wQ2phajNnVEU5MFJFalFXOUZaT0Rnam5mTVlUXzJqRHA5ZlhXYjJWdkZpSERyRTRCdllZRVFHZWNHUWpycldlc29MRXBnbnVoaXNIVGJ4SF8yM0FuVmJvMmNxQ0NFTmt0R2hETF9wSDRHTC1qaXlqRWY5VTRta09aWVFGYkVWZ0FkeDZQUk5HTHFIaklJcVlzcGtsZ3FWelVRZTNjVUNwdEpsLUdXMkUtdGJoT0RiNA?oc=5","Wed, 30 Sep 2026 12:58:39 GMT","Niagen Bioscience signs agreement for clinical trial planning By Investing.com Investing.com India","Investing.com India"]